Genomic Relevance of FGFR2 on the Prognosis of HCV-Induced Hepatocellular Carcinoma Patients
Open Access
- 30 May 2022
- journal article
- research article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (11) , 3093
Abstract
The Fibroblast Growth Factor Receptors (FGFRs) are known to regulate cancer metabolism in different tumor types, including hepatocellular carcinoma (HCC). Several risk factors are associated with HCC, of which viral infections (Hepatitis B and C) and cirrhosis are prominent. In Pakistan as well as in highly developed countries like the United States, hepatitis C virus HCV infections are most commonly reported in HCC. Here, we aimed to investigate the clinical relevance of FGFR receptors in HCC and their role in HCV-positive HCC cases. 264 HCC samples along with their clinical information and 96 normal liver samples were collected. qPCR was done to estimate the expression of FGFR1, FGFR2, FGFR3 and FGFR4. Three independent HCV-induced HCC cohorts (containing 293 HCC samples) were used for validation. According to in vitro results, FGFR1 was upregulated in HCV+ HCC patients. However, in all three independent cohorts of HCC, significant a down-regulation of FGFR1 was observed. FGFR2 overexpression was observed in the in vitro cohort as well as in three independent HCC cohorts. Interestingly, a strong correlation of FGFR2 expression was observed between cirrhosis and HCV in all four HCC cohorts. Our study suggested that FGFR2 expression can be used to classify HCC patients based on HCV infection. This FGFR2-based classification may lead to new therapeutic strategies against HCV-positive HCC subtypes.Keywords
Funding Information
- Institutional Fund Projects (IFFPP-105-22)
This publication has 32 references indexed in Scilit:
- Hepatocellular Carcinoma in Pakistan: National Trends and Global PerspectiveGastroenterology Research and Practice, 2016
- Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor ActivityMolecular Cancer Therapeutics, 2015
- Fibroblast growth factor receptor 3 isoforms: Novel therapeutic targets for hepatocellular carcinoma?Hepatology, 2015
- Fibroblast Growth Factor Receptor 4 Polymorphism Is Associated with Liver Cirrhosis in HepatocarcinomaPLOS ONE, 2015
- Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinomaClinical and Molecular Hepatology, 2015
- Epidemiology of Viral Hepatitis and Hepatocellular CarcinomaGastroenterology, 2012
- Mechanisms of FGFR-mediated carcinogenesisBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2012
- FGFR2 alterations in endometrial carcinomaLaboratory Investigation, 2011
- Fibroblast growth factors: from molecular evolution to roles in development, metabolism and diseaseThe Journal of Biochemistry, 2010
- Environmental factors and risk for hepatocellular carcinomaGastroenterology, 2004